Pharma Law USA

FDA Regulatory partner, George O’Brien will discuss “Hot Topics in Patents including Orange Book Cases & Patent Eligibility” on October 8 at this year’s Pharma Law USA conference in Boston presented by Informa. The panel will address:

• Review of FTC’s notice for Orange Book patent violations
• Cooperation between FTC, FDA and Patent and Trademark Office
• How should patents be managed and granted?
• Is there an alternate way to force more generic substitution?
• Patent eligibility: lessons learnt from Regeneron Vs Kymab and Revised Patent Subject Matter Eligibility Guidance
• FDA’s 30-month preliminary injunctions: can they result in anti-trust violations?

For more information and to register, please visit the event webpage.